Inventor · disambiguated record
John David Ginn
Also filed as: GINN JOHN · GINN JOHN D · GINN JOHN DAVID
15 granted patents·8 pending applications·92 citations·filing 2003–2023
91Inventor score
Files withAERIE PHARMACEUTICALS INC4BOEHRINGER INGELHEIM INT4UNIV CORNELL4BOEHRINGER INGELHEIM PHARMA3BOSANAC TODD2
Top patents by PatentIndex Score
23 records- 0194US8809326B2Isoquinolinone Rho kinase inhibitorsBOSANAC TODD·Filed 2007·Granted Aug 19, 2014·40 cites·5 claims
- 0285US6974870B2Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their usesBOEHRINGER INGELHEIM PHAMACEUT·Filed 2003·Granted Dec 13, 2005·23 cites·5 claims
- 0382US9353090B2Heterocyclic carboxylic acids as activators of soluble guanylate cyclaseBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 31, 2016·6 cites·45 claims
- 0478US8906904B2Alkoxy pyrazoles as soluble guanylate cyclase activatorsBRENNEMAN JEHROD BURNETT·Filed 2013·Granted Dec 9, 2014·5 cites·35 claims
- 0575US11834515B2Macrocyclic compounds as proteasome inhibitorsUNIV CORNELL·Filed 2018·Granted Dec 5, 2023·1 cites·12 claims
- 0675US9079880B2Rho kinase inhibitorsGINN JOHN DAVID·Filed 2011·Granted Jul 14, 2015·4 cites·11 claims
- 0772US12473331B2Macrocyclic compounds as proteasome inhibitorsUNIV CORNELL·Filed 2023·Granted Nov 18, 2025·0 cites·14 claims
- 0872US7550473B2Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jun 23, 2009·6 cites·13 claims
- 0971USRE46886EAlkoxy pyrazoles as soluble guanylate cyclase activatorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Jun 5, 2018·1 cites·43 claims
- 1071US2014357652A1Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1169US10624882B2Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Apr 21, 2020·0 cites·19 claims
- 1269US8952004B2CXCR3 receptor antagonistsGINN JOHN DAVID·Filed 2011·Granted Feb 10, 2015·2 cites·8 claims
- 1366US8362249B2CXCR3 receptor antagonistsBOEHRINGER INGELHEIM INT·Filed 2010·Granted Jan 29, 2013·1 cites·2 claims
- 1465US7329764B2Substitute benzothiophene compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Feb 12, 2008·2 cites·3 claims
- 1564US8815857B2Soluble guanylate cyclase activatorsBOSANAC TODD·Filed 2012·Granted Aug 26, 2014·1 cites·15 claims
- 1662US2023286955A1Inhibitors of them1UNIV CORNELL·Filed 2023·Application pending·0 cites
- 1761US2024343726A1Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferationUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 1860US2016243102A1Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1958US2015297581A1Rho kinase inhibitorsAERIE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2054US2024132480A1Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenaseUNIV CORNELL·Filed 2022·Application pending·0 cites
- 2152US2004242613A1Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2251US2023137893A1PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSSUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 2349US7592353B2Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their usesBOEHRINGER INGELHEIM INT·Filed 2007·Granted Sep 22, 2009·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when John David Ginn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →